EMPEROR Reduced Trial Evidences Benefit of Heart Failure Prevention Drug Empagliflozin
Milton Packer, MD, is a distinguished scholar in cardiovascular science working out of Baylor University Medical Center in Dallas. The […]
Western Ireland’s University Hospital Galway Leading Advanced Heart Failure Monitoring Clinical Trial
Cardiology-focused Investigators from University Hospital Galway complete a first-in-man clinical trial for a sensor that may help patients with heart […]
AHA-Backed Study Reveals Ongoing Lack of Minority & Female Participation in Cardiometabolic Clinical Trials
Unfortunately, yet another report reveals the dearth of women and minorities, especially African Americans’ representation in clinical trials in the […]
University of Utah-led Study Reveals Powerful AI-based Technology can Predict Hospitalization for Heart Patients
Investigators from the University of Utah Health and VA Salt Lake City Health Care System conclude from a recent study […]
Yale University Meta Analyses Finds Type 2 Diabetes Drug Avandia Boosts Cardiovascular Risk by Up to 33%
A new study conducted by Yale School of Public Health finds that Rosiglitazone (Avandia), a drug developed to treat type […]
Researchers Trace Molecular Roots of Potentially Deadly Heart Condition and Reveal a Promising Future Treatment
A multi-center preclinical research team involving Harvard Medical School, Brigham and Women’s Hospital, University of Oxford, and other prestigious research […]
Unity Point Health St. Luke’s Leads Clinical Trial Targeting Chronic Heart Failure Sees Positive Results
UnityPoint Health St. Luke’s Heart and Vascular Institute in Cedar Rapids recently became the first in an international clinical trial to […]
UnityPoint Health—St. Luke’s Cedar Rapids Leads the Way for Clinical Trial of Therapy to Combat Heart Failure
St. Luke’s in Cedar Rapids became the first site in an international clinical trial to test a new device that […]
WIMR Preclinical Research Reveals Experimental Treatment for Heart Attack Scar Could Address Heart Failure
Researchers from The Westmead Institute for Medical Research (WIMR) and the University of Sydney produced a study revealing that a protein […]
New Cardiovascular Drug on the Rise: ORION-10 & the Novartis $9.7 Billion Purchase
ORION-10 was the second of three 19-month Phase III clinical trials for inclusion for lowering cholesterol. Funded by sponsor The […]
